Butafosfan

Product Details

CAS No:17316-67-5

MF:C7H18NO2P

Appearance:white or off-white crystalline powder

Specification:98.5%

UN number:-

Package:1/5/10/25kgs/drum

Supply Capacity:MT

Synonyms:Butaf;2-(butylamino)propan-2-yl-hydroxy-oxophosphonium;1-(butylamino)-1-methylethyl]-phosphonic acid;Butaf02759847255osfan;2-(butylamino)propan-2-yl-hydroxy-oxophosphanium;BUTAFOSFAN;BUTAPHOSPHAN(BUTAFOSFAN);Phosphinic acid, 1-(butylamino)-1-methylethyl-; RefChem:857908; P-(1-(Butylamino)-1-methylethyl)phosphinic acid; 241-341-7; (1-(Butylamino)-1-methylethyl)phosphinic Acid; 17316-67-5; 2-(butylamino)propan-2-yl)phosphinic acid; 3Q2LQ1149L; Butafosfan; Butafosfanum; C7H18NO2P; Coforta; DTXCID1028607; DTXSID5048681

Product application:Butafosfan,17316-67-5,Butaphosphan,1-(Butylamino)-1-methylethyl-phosphinic acid,P-[1-(Butylamino)-1-methylethyl]phosphinic acid,Veterinary grade butafosfan,Injectable grade butafosfan,Catosal raw material,Animal metabolic stimulant,Organic phosphorus supplement,Bovine ketosis treatment API,Sow postpartum recovery agent,Piglet growth promoter,Poultry anti-stress additive,Aquaculture hepatoprotective agent,Nonspecific immune booster,Muscle fatigue recovery supplement,Low free amine butafosfan,Ultra-pure Butafosfan 99.5%,CAS 17316-67-5 supplier,Butafosfan manufacturer China,Suzhou Health Chemicals veterinary APIs,Butafosfan wholesale bulk export

 

Butafosfan is widely utilized across veterinary pharmaceutical manufacturing, commercial livestock and poultry husbandry, aquaculture hepatoprotective nutrition, and companion animal metabolic therapeutics. In veterinary medicine and animal healthcare formulations, universally recognized as a premier organic phosphorus metabolic stimulant, it directly accelerates the cellular ADP-to-ATP bioenergetic cascade within the citric acid cycle; this stimulatory action promotes hepatic gluconeogenesis, elevates liver glycogen reserves, and enhances hepatic detoxification pathways; routinely formulated with cyanocobalamin into parenteral sterile solutions, it operates as a frontline active ingredient for managing bovine transition metabolic disorders, including negative energy balance, subclinical ketosis, and post-parturient recumbency in high-yielding dairy herds, while facilitating myometrial contraction and uterine involution during puerperium; in intensive swine and commercial poultry operations, it functions as a potent physiological adaptogen that mitigates environmental, handling, vaccination, and heat-induced oxidative stress; by dampening excess corticosteroid cascades, stimulating nonspecific immune responses, and replenishing phosphocreatine reserves across striated skeletal muscles, it accelerates physical fatigue recovery, increases feed intake, and improves daily weight gain metrics without undesirable tissue residues; in aquaculture science, it serves as a metabolic stabilizer to resolve hepatic lipid accumulation in teleost species and marine crustaceans; furthermore, in equine sports medicine and canine clinical care, Butafosfan provides an exceptionally safe, non-toxic energy-replenishing agent that supports physiological homeostasis and sustained performance across diverse species.